top
Daily pill doubles survival time for pancreatic cancer patients
Key takeaways
- A pill has been found to almost double the survival time for advanced pancreatic cancer patients, with experts describing the trial as a game changer.
- The drug, called daraxonrasib, appears to be a breakthrough in managing a disease that has the highest mortality rate of all major cancers.
- It helps prevent the spread of cancer by locking onto and shutting off the mutated KRAS gene, which is in more than 90% of pancreatic tumours and spurs cancer growth.
Why this matters: a developing story that could shape the day's news cycle.
Chris Graham Reuters. A pill has been found to almost double the survival time for advanced pancreatic cancer patients, with experts describing the trial as a game changer.
The drug, called daraxonrasib, appears to be a breakthrough in managing a disease that has the highest mortality rate of all major cancers.
It helps prevent the spread of cancer by locking onto and shutting off the mutated KRAS gene, which is in more than 90% of pancreatic tumours and spurs cancer growth.
Article preview — originally published by BBC News. Full story at the source.
Read full story on BBC News →
More top stories
Also covered by
Fortune
Experimental pill nearly doubles survival time for people with advanced pancreatic cancer. ‘I actually started crying’
The Guardian
Daily pill can double survival time for world’s deadliest cancer, trial shows
NPR News
Experimental pill promises new hope for deadly pancreatic cancer
Le Monde (English)
Pancreatic cancers: New drug doubles survival rate as France rolls out prevention program
Aggregated and edited by the Scoop newsroom. We surface news from BBC News alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop